RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
NCT07506668
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Relapsed/Refractory B-cell Lymphoma
Interventions
BIOLOGICAL:
RN1701 injection
Sponsor
Affiliated Hospital of Nantong University